CD44 and cancer: This suggests that CD44 is not constituitively expressed in invadopodia but may be recruited there only upon a sufficiently high concentration of its agonist, hyaluronan, which can be concentrated at the invasive front of tumors and may be important in cancer stem cell-niche interactions [84].